Exact Mass: 360.05800300000004
Exact Mass Matches: 360.05800300000004
Found 51 metabolites which its exact mass value is equals to given mass value 360.05800300000004,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
4-Hydroxy-3-(2'-hydroxy-[1,1'-biphenyl]-4-yl)-6-oxo-6,7-dihydrothieno[2,3-b]pyridine-5-carbonitrile
C20H12N2O3S (360.0568602000001)
Ritipenem acetoxymethyl ester
ethyl loflazepate
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
1,3,6,8-Tetrahydroxy-7-hydroxymethyl-9,10-dioxo-9,10-dihydro-anthracen-2-carbonsaeure-methylester|1,3,6,8-tetrahydroxy-7-hydroxymethyl-9,10-dioxo-9,10-dihydro-anthracene-2-carboxylic acid methyl ester|2-Hydroxymethyl-1,3,6,8-tetrahydroxyanthrachinon-7-carbonsaeure-methylester|Rhodocadonsaeure
(3Z,11Z,7S*,9R*,10R*)-13-methoxy-6-chloro-9-bromo-7:10-epoxypentadeca-3,11-dien-1-yne
3,3,4-tri-O-methylflavellagic acid|3,3,4-trimethoxyflavellagic acid
Urea, N-(3,4-dichlorophenyl)-N-(5,7-dimethyl-1,8-naphthyridin-2-yl)- (9CI)
A-769662
C20H12N2O3S (360.0568602000001)
A-769662 is a potent, reversible AMPK activator with EC50 of 0.8 μM.
1-[3,6-bis(4-chlorophenyl)-1H-1,2,4,5-tetrazin-2-yl]propan-1-one
2-(1,3-Benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole
C17H13FN2O4S (360.05800300000004)
N-[(2-methyl-4-thiazolyl)methyl]-4-phenoxybenzenesulfonamide
N-[(E)-(6-chloro-1,3-benzodioxol-5-yl)methylideneamino]-2,3-dihydro-1,4-benzodioxine-6-carboxamide
C17H13ClN2O5 (360.05129580000005)
(1S,3S,11R,11aR)-3-amino-1,7,11-trihydroxy-4-oxo-1,3,4,6,11,11a-hexahydro-2H-pyrido[1,2-b]isoquinolin-8-yl hydrogen sulfate
N-(5-chloro-2-pyridinyl)-2-[(1-phenyl-5-tetrazolyl)thio]propanamide
C15H13ClN6OS (360.05600380000004)
1-(4-Fluorophenyl)-3-methyl-5-thieno[2,3-c]pyrazolecarboxylic acid (2-oxo-3-oxolanyl) ester
C17H13FN2O4S (360.05800300000004)
5-[(2-Bromophenyl)methyl]-1-tert-butyl-4-pyrazolo[3,4-d]pyrimidinone
N-[[[(2-hydroxyphenyl)-oxomethyl]hydrazo]-sulfanylidenemethyl]-2-nitrobenzamide
fumisoquin B zwitterion
A zwitterion obtained by transfer of a proton from the sulfate to the amino group of fumisoquin B; major species at pH 7.3.
fumisoquin B
A pyridoisoquinoline that is (11aR)-1,3,4,6,11,11a-hexahydro-2H-pyrido[1,2-b]isoquinoline substituted by hydoxy groups at positions 1S,7 and 11R, by an amino group at position 3S, oxo group at position 4 and a sulfooxy group at position 8. It is produced by a biosynthetic gene cluster called fsq in the human pathogen Aspergillus fumigatus.
(2r,3r,5s)-3-bromo-5-(1-chlorohex-3-en-5-yn-1-yl)-2-(3-methoxypent-1-en-1-yl)oxolane
5-chloro-6-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-8-hydroxy-3-methyl-3,4-dihydro-2-benzopyran-1-one
6,12-dihydroxy-7,13,14-trimethoxy-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4(16),5,7,11,13-hexaene-3,10-dione
3,5,3′- tri- Omethylflavellagic acid
{"Ingredient_id": "HBIN007535","Ingredient_name": "3,5,3\u2032- tri- Omethylflavellagic acid","Alias": "NA","Ingredient_formula": "C17H12O9","Ingredient_Smile": "COC1=C(C=C2C3=C1OC(=O)C4=C3C(=C(C(=C4O)OC)OC)OC2=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41520","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
{3-amino-1,7,11-trihydroxy-4-oxo-1h,2h,3h,6h,11h,11ah-pyrido[1,2-b]isoquinolin-8-yl}oxidanesulfonic acid
(7z)-10-(3-bromopropa-1,2-dien-1-yl)-12-methyl-11,13-dioxabicyclo[7.3.1]tridec-7-ene-2,4,5-triol
C15H21BrO5 (360.05722760000003)
4-hydroxy-3-[(1-hydroxy-3,4-dioxonaphthalen-2-yl)methyl]naphthalene-1,2-dione
3-bromo-5-(1-chlorohex-3-en-5-yn-1-yl)-2-(3-methoxypent-1-en-1-yl)oxolane
(1s,2r,4r,5r,7z,9r,10r,12s)-10-(3-bromopropa-1,2-dien-1-yl)-12-methyl-11,13-dioxabicyclo[7.3.1]tridec-7-ene-2,4,5-triol
C15H21BrO5 (360.05722760000003)
(2r,3r,5s)-3-bromo-5-[(1r,3z)-1-chlorohex-3-en-5-yn-1-yl]-2-[(1z,3r)-3-methoxypent-1-en-1-yl]oxolane
4-(3-bromopropa-1,2-dien-1-yl)-2-methyl-3,13-dioxabicyclo[8.2.1]tridec-5-ene-7,9,12-triol
C15H21BrO5 (360.05722760000003)
5-hydroxy-16-methyl-13,21-dioxapentacyclo[12.8.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]docosa-1(14),2(11),4,6,8,15,17,19-octaene-3,10,22-trione
8-hydroxy-6,15-dimethyl-12,20-dioxapentacyclo[11.8.0.0²,¹¹.0⁴,⁹.0¹⁴,¹⁹]henicosa-1(13),2(11),4,6,8,14(19),15,17-octaene-3,10,21-trione
(2r,3r,5s)-3-bromo-5-[(3z)-1-chlorohex-3-en-5-yn-1-yl]-2-[(1z)-3-methoxypent-1-en-1-yl]oxolane
(1s,2s,4s,5e,7r,9s,10s,12r)-4-(3-bromopropa-1,2-dien-1-yl)-2-methyl-3,13-dioxabicyclo[8.2.1]tridec-5-ene-7,9,12-triol
C15H21BrO5 (360.05722760000003)
2-hydroxy-3-[(3-hydroxy-1,4-dioxonaphthalen-2-yl)methyl]naphthalene-1,4-dione
10-(3-bromopropa-1,2-dien-1-yl)-12-methyl-11,13-dioxabicyclo[7.3.1]tridec-7-ene-2,4,5-triol
C15H21BrO5 (360.05722760000003)
